Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-02

FDA Approved: SUCRALFATE — Original Application (AvPAK)

View source ↗

Summary

FDA approved the original ANDA for sucralfate oral, enabling generic marketing by AvPAK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUCRALFATE (SUCRALFATE)

Snippet

ORIG AP for SUCRALFATE (SUCRALFATE ORAL)